Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
NCT01529437
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Allergies
Allergic Rhinitis
Asthma
Interventions
DRUG:
sublingual immunotherapy
DRUG:
placebo sublingual immunotherapy
Sponsor
Stanford University